1345.HK Shanghai Pioneer Holding Ltd
HKSEHealthcareAs of 2026-08-28 15:36
Why 1345.HK matters now
Shanghai Pioneer Holding Ltd (1345.HK) is a Hong Kong stock in Healthcare. The latest InvestLog snapshot shows HK$2.24 with +4.19% on the session and HK$2.60B in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 17.92, gross margin 51.8%, and operating margin 10.5%.
InvestLog's latest related AI research is a Earnings Release note titled "Shanghai Pioneer Holding Ltd (1345.HK) 2026 H1 financial results".
Valuation
P/E (TTM)
17.92
PEG
—
P/B
2.14
P/S
1.80
EV/EBITDA
13.88
DCF Value
—
FCF Yield
6.2%
Div Yield
5.3%
Margins & Returns
Gross Margin
51.8%
Operating Margin
10.5%
Net Margin
9.9%
ROE
11.8%
ROA
7.6%
ROIC
6.5%
Listing Info
Market
Hong Kong
Exchange
HKSE
Currency
HKD
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
CN
China Pioneer Pharma Holdings Limited operates as an investment holding company, primarily focusing on the marketing, promotion, and distribution of pharmaceutical goods and medical devices within mainland China. The firm maintains an extensive portfolio of pharmaceutical products addressing diverse therapeutic areas, including ophthalmology, pain management, cardiovascular health, immunology, gynecology, and gastroenterology. Its medical device offerings encompass solutions for ophthalmology, orthopedics, dentistry, and wound care. The company supplies its products to a wide client base, including hospitals, various medical institutions, and pharmacies. Additionally, it engages in the sale of supporting tools, leases related equipment, provides dental apparatus, and distributes imported prescription products under license. Established in 1996, China Pioneer Pharma Holdings Limited is headquartered in Shanghai, PRC, and functions as a subsidiary of Pioneer Pharma (BVI) Co., Ltd.